QuickView for NF-κB inhibitors (compound)

1. Burkitt lymphoma cell treated with serine protease inhibitor TPCK or NF-κB inhibitor Bay 11-7082
2. Chronic myeloid leukemia K562 cells showing Imatinib-resistance or sensitivity
3. Colorectal cancer cells treated with BET inhibitor JQ1 alone or in combination with bortezomib
4. Breast adenocarcinoma SKR6 cells activation of NF-KB pathway and lapatinib resistance
5. Embryonic kidney HEK293T cells expressing α-amanitin resistant RNAPolII variants

There were no matches for NF-κB inhibitors

1. Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (Mp…
2. Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis
3. Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphom…
4. Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)
5. VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma